Biomoda, Inc. – Trademark Portfolio

Entity Type: 03

Biomoda, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CYPATH. The owner is based in ALBUQUERQUE, NM.

8301 WASHINGTON ST NE

ALBUQUERQUE, NM 87113

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BIOMODA
BIOMODA
Abandoned 2010
CYDX
CYDX
Cancelled 2004
CYPATH
CYPATH
Registered 2004
CYTORED
CYTORED
Abandoned 2004
NEOCYTE
NEOCYTE
Abandoned 2004

Trademark Classifications

Biomoda, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Biomoda, Inc. have?

Biomoda, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 1 cancelled.

What trademark classes does Biomoda, Inc. file in?

Biomoda, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Biomoda, Inc.'s most well-known trademarks?

Biomoda, Inc.'s registered trademark portfolio includes well-known marks such as CYPATH. These are among 1 currently registered trademark in the portfolio.

What is Biomoda, Inc.'s trademark registration success rate?

Biomoda, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.